The biotech industry needs a data interchange standard that translates like the batch machine learning and XML standards that are used in manufacturing but are not yet used between R&D and manufacturing. When such a standard is developed, implementing machine learning will be simpler than ever.
Praha Vaccines’ assets include a 150,000-square foot vaccine and biologics manufacturing facility and other support buildings in Bohumil, Czech Republic, which Novavax expects will deliver an annual capacity of over 1 billion doses of antigen starting in 2021 for NVX-CoV2373, the company's COVID-19 vaccine candidate.
Pfenex Scores Government Contract to Develop Production Process for Bulk Recombinant Protective Antigen from...
BARDA funding could total $18.8 million if all milestones are met and options and extensions are made.
Quanterix plans to launch an IPO of at least $64 million, with proceeds set in part toward expanding commercial operations and supporting the planned rollout next year of its new Quanterix SR-X Ultra-Sensitive Biomarker Detection System™
A therapeutic protein or monoclonal antibody (mAb) can be turned into an effective therapy and a revenue-generating product only if it can be efficiently filtered from the process stream. If a product is inefficiently...
When new technologies are deployed, there’s always a fly in the ointment. In the case of single-use technology, extractables and leachables must be swatted away.
Regenerative medicine looks forward to the industrial-scale production of diverse tissues. Eventually, treatments may grant patients something like the powers of a superhero—a Salamander Man—when needed.
Biopharmaceutical production depends on buffers. Making sure the right buffer solutions are available, in the right place on the manufacturing line, at the right time, and in the right quantity, is a considerable challenge.
French scientists developed a protocol where hPSC cells were exposed to three different cytokines in sequence. This protocol was then transferred to a cell culture robot to help upscale the production process. The approach allowed the team to increase the yield of RPE cells they could obtain and allowed them to use automatic treatments.
Please wait while you are redirected to the right page...